Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) has shared an update.
Bafna Pharmaceuticals Limited has submitted its annual disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, to the stock exchanges. This disclosure, received from the company’s promoters, is a regulatory requirement that provides transparency about substantial share acquisitions and takeovers, ensuring stakeholders are informed about the company’s shareholding structure.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Chennai, India, and is known for its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 1,038
Current Market Cap: 1.85B INR
For a thorough assessment of BAFNAPH stock, go to TipRanks’ Stock Analysis page.